| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.35 | 0.02 |